Home » Newsletters » BioWorld Science

BioWorld Science

April 16, 1997

View Archived Issues

Nippon Kayaku isolates novel antitumor agents

Antitumor indane derivatives from Taiho

Pola discloses antitumor/immunosuppressive agents

5-HT2 antagonists/5-HT reuptake inhibitors described by Yamanouchi

Meiji Seika discloses new cardiotonic agents

Esters of estrogenic compounds from Lilly

Placebo associated with improvement and side effects in treatment of BPH

Novel aggregation pathway identified

Optimal dose of sertraline for premature ejaculation

DiagnoCure licenses growth factor derivatives for cancer diagnosis/therapy

Mechanism of HCV resistance to interferon discovered

Matrix issued U.S. patent for drug delivery technology; preclinical data presented

Amgen and Roche extend EU collaboration on G-CSF products

Generic minoxidil receives FDA approval

Isis receives contract for combinatorial antibacterial drug research

Another minoxidil generic approved in U.S. for women

Supplemental BLA submitted in U.S. for Proleukin

Oxford Molecular Group and ImmunoGen join efforts in humanized antibody development

Focus on sildenafil for erectile dysfunction

CVT-124 enters phase II trials for CHF

HIV viral replication halted using Eukarion's antibody lipidation technology

Potential BPH therapy from Abbott

New bladder-selective M3 antagonist reported by Yamanouchi

ImClone reports research results from its anti-flk-1 monoclonal antibody program

Biogen reveals new cell adhesion inhibitor

Potent and selective ETA antagonist from SKB

C225 effective in mouse model of human bladder cancer

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...